Pharmacovigilance for antiretroviral drugs in Africa lessons from a study in Abidjan Cote d’Ivoire

摘要

BackgroundWhile antiretroviral treatment (ART)-related adverse drug reactions (ADR) are documented in industrialized countries, there is no pre-existing surveillance system dedicated to ADR monitoring in most African countries. We assessed knowledge towards pharmacovigilance among ART prescribers and available capacity of HIV clinics to conduct ADR monitoring in Abidjan, Côte d’Ivoire.